Skip to main content
OpenTrials

Clinical trial condition

Digestive System Diseases

Explore clinical trials studying Digestive System Diseases. Study availability and eligibility vary by location and protocol.

31,870 public trials 5,691 recruiting studies
Refine in advanced search Browse all conditions

Digestive System Diseases trial results

Recruiting

A Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors

NCT07213609

Conditions
Colonic Diseases, Colonic Neoplasms, Colorectal Neoplasms, +22 more
Locations
  • GSK Investigational Site Aurora, Colorado, United States
  • GSK Investigational Site Detroit, Michigan, United States
  • GSK Investigational Site Canton, Ohio, United States
  • GSK Investigational Site Nashville, Tennessee, United States
View all 22 locations
View Trial Details
Recruiting

DRAGON Registry - International Multicenter Registry and Medical Image Bank for Patients With Primarily Unresectable Liver Cancer or Liver Metastases That Underwent Combined Portal and Hepatic Vein Embolization (PVE/HVE) to Increase Future Liver Remnant Before Resection.

NCT07717437

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +12 more
Locations
  • Rush University Medical Center Chicago, Illinois, United States
  • Mayo Clinic Rochester, Minnesota, United States
  • Cleveland Clinic Cleveland, Ohio, United States
  • Monash Medical Centre Clayton, Victoria, Australia
View all 31 locations
View Trial Details
Recruiting

Development of a Prediction Score for the Occurrence of Death or Lung Transplantation in Patients With Emphysema Secondary to Alpha-1-anti-tripsin Deficiency

NCT07715617

Conditions
Alpha-1-antitrypsin Deficiency, Artificial Intelligence (AI), Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +13 more
Locations
  • Hospices Civils de Lyon Bron, France
  • CHU de Lille Lille, France
  • Hôpital BICHAT CLAUDE-BERNARD Paris, France
  • Bordeaux University Hospital Pessac, France
View Trial Details
Recruiting

A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)

NCT07221253

Conditions
Biliary Tract Cancer, Biliary Tract Diseases, Biliary Tract Neoplasms, +10 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site Phoenix, Arizona, United States
  • Research Site Tucson, Arizona, United States
  • Research Site Duarte, California, United States
View all 174 locations
View Trial Details

Related conditions